Overview
Human liver tissue has been found to contain micro- and nanoplastics (MNPs), with evidence that hepatic MNP accumulation has significantly increased over the last 10 years, prompting critical questions regarding their potential causal role in liver disease.
In cell-based and murine models, MNP exposure can trigger oxidative stress, fibrogenesis, and inflammation – pathological features that resemble those of advanced liver disease and cirrhosis, suggesting shared mechanistic pathways. Furthermore, the capacity for MNPs to act as 'Trojan horses' for microbial pathogens, antimicrobial resistance, endocrine-disrupting chemicals and carcinogenic additives may have important implications for liver pathology. Currently, major knowledge gaps remain regarding the mechanistic pathways, causal links, and clinical relevance of MNP exposure in liver health.
The PILI project investigates how plastics and their associated chemicals, alcohol and dietary lipids interact to injure the liver and accelerate the progression of alcohol-related liver disease and metabolic dysfunction associated steatotic liver disease.
Using human relevant new approach models, including precision cut liver slices, hepatic organoids, patient-derived liver organoids and gut–liver microphysiological systems, this project defines the cellular and molecular events triggered by plastic exposure under healthy and disease relevant conditions. Integrated multi-omics profiling, spatial imaging and bioinformatics will reveal how plastics alter hepatocyte function, disrupt the gut barrier, activate inflammation and promote fibrosis.